Dr. James Robert McFarlin, MD

Dr. McFarlin practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. McFarlin's NPI, 1255900502, was assigned on June 22, 2021. Dr. McFarlin graduated from New York Medical College in 2021. Dr. McFarlin holds Missouri license 2024027712.

Dr. McFarlin's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000.

Dr. McFarlin's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McFarlin practices. Vendor and product names are available with a free account.

Internal medicine is Dr. McFarlin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. McFarlin is licensed in Missouri.

CMS data shows 41 Medicare services from Dr. McFarlin across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $1,396 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. McFarlin in 2024. The largest group is under 65, with 19 patients. 75% of them have high blood pressure, and 49% have high cholesterol. 64% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McFarlin's median patient age at 71, with 80% women.

In 2024, Dr. McFarlin wrote 475 Medicare Part D claims for 64 patients. 78% of them were for generic drugs. CMS names the drug for 227 of them, across 11 drugs with 11 or more claims each, at $37,965 in total drug cost. In 2023, CMS named 315 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. McFarlin for performance year 2024, reported as part of a group.

CMS Open Payments shows 4 general payments to Dr. McFarlin from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $131.

Dr. McFarlin graduated from New York Medical College in 2021.